In a research study published today in the journal Oncogene, scientists from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that by therapeutically targeting the receptor for advanced glycation end-products (RAGE) in breast cancer cells, they decreased tumor growth, reduced tumor angiogenesis and recruitment of inflammatory cells, and dramatically decreased metastasis to the lung and the liver.
Dr. Charles Vogel, a breast oncologist at Sylvester at Deerfield Beach, discusses the role of clinical trials in breast cancer treatment and how they target the cancer’s underlying genetic defects.
Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine researchers Priyamvada Rai, Ph.D., associate professor of medicine/hematology and oncology, and Kerry Burnstein, Ph.D., professor of molecular and cellular pharmacology, have received a $1.15 million Idea Development Award from the Department of Defense (DOD) to investigate a novel mechanism of inhibiting incurable prostate cancer.
The lung cancer screening program at Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has been designated an American College of Radiology (ACR) Lung Cancer Screening Center. The voluntary designation signifies that the program and protocol meet the requirements set forth by the ACR lung cancer screening committee.
Armed with a new $3.4 million grant from the National Cancer Institute (NCI), an interdisciplinary research team of Sylvester Comprehensive Cancer Center members is creating a blueprint that may help to deliver safer, more-effective chemotherapy, with far fewer long-term negative health consequences.
Spurred on by first-hand experience, Stanley and Nancy Engle recently made a generous commitment to help ease the difficulties facing brain tumor patients. The couple announced a $400,000 gift for a joint initiative of the Sylvester Comprehensive Cancer Center and the Department of Neurological Surgery at the University of Miami Miller School of Medicine known as the UM Brain Tumor Initiative.
Theodore J. Lampidis, Ph.D., a cell biology and anatomy expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, recently received recognition from the 144th Congress of the United States in honor of his work studying the combination of two non-toxic drugs as a universal treatment for cancer.
The Miami Epigenetics & Cancer Symposium, hosted by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, will be held at the Ritz-Carlton, Miami Beach on November 28-29. The symposium will bring together world-renowned scientists to discuss the latest discoveries in genomic and epigenetic approaches to understanding the molecular underpinning of cancer development and progression.
Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has announced that it is partnering with the Florida Panthers for Hockey Fights Cancer. On October 22, the partnership will kick off with the Viktor E. Dash 5K Race at the BB&T Center, where fans can sign up to help support the National Hockey League’s Hockey Fights Cancer initiative.